Rafik Haderbache
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CMTM6 suppresses cell-surface expression of death receptor FAS in mice but not in humans.
Journal: EMBO reports
Published: May 10, 2025
Correction: RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.
Journal: Gene therapy
Published: December 20, 2024
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.
Journal: Gene therapy
Published: November 07, 2022
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Journal: Current research in translational medicine
Published: July 18, 2022
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Journal: Journal for immunotherapy of cancer
Published: June 27, 2022
Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro.
Journal: Immunologic research
Published: January 04, 2022
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.
Journal: Journal of translational medicine
Published: April 25, 2021
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch.
Journal: Cancer gene therapy
Published: September 06, 2020
IL-1RAP as a candidate for CAR T-cells immunotherapy
Journal: Medecine sciences : M/S
Published: July 06, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026